These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18666714)

  • 21. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolism.
    Brougham LR; Conway PG; Ellis DB
    Neuropharmacology; 1991 Oct; 30(10):1137-40. PubMed ID: 1684649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of clonidine with dopamine-dependent behaviour in rodents.
    Pycock CJ; Jenner PG; Marsden CD
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):133-41. PubMed ID: 558529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function.
    Abdallah L; Bonasera SJ; Hopf FW; O'Dell L; Giorgetti M; Jongsma M; Carra S; Pierucci M; Di Giovanni G; Esposito E; Parsons LH; Bonci A; Tecott LH
    J Neurosci; 2009 Jun; 29(25):8156-65. PubMed ID: 19553455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function.
    Csernansky JG; Glick S; Mellentin J
    Psychopharmacology (Berl); 1987; 91(4):440-4. PubMed ID: 3108924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.
    Kääriäinen TM; Lehtonen M; Forsberg MM; Savolainen J; Käenmäki M; Männistö PT
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):50-8. PubMed ID: 17971064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxytocin-conjugated saporin injected into the substantia nigra of male rats alters the activity of the nigrostriatal dopaminergic system: A behavioral and neurochemical study.
    Sanna F; Bratzu J; Angioni L; Pina Sorighe M; Cocco C; Argiolas A; Melis MR
    Brain Res; 2021 Dec; 1773():147705. PubMed ID: 34744015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unilateral lesion of the nigrostriatal pathway decreases the response of interneurons in medial prefrontal cortex to 5-HT 2A/2C receptor stimulation in the rat.
    Zhang QJ; Wang S; Liu J; Ali U; Gui ZH; Wu ZH; Hui YP; Wang Y; Chen L
    Brain Res; 2010 Feb; 1312():127-37. PubMed ID: 19948151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex.
    Pehek EA; Bi Y
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 May; 21(4):671-82. PubMed ID: 9194148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.
    Han M; Huang XF; Deng C
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.
    Marquis KL; Sabb AL; Logue SF; Brennan JA; Piesla MJ; Comery TA; Grauer SM; Ashby CR; Nguyen HQ; Dawson LA; Barrett JE; Stack G; Meltzer HY; Harrison BL; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2007 Jan; 320(1):486-96. PubMed ID: 17038512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats.
    Uvnäs-Moberg K; Alster P; Svensson TH
    Psychopharmacology (Berl); 1992; 109(4):473-6. PubMed ID: 1365865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects.
    Svartengren J; Pettersson E; Björk A
    Biol Psychiatry; 1997 Aug; 42(4):247-59. PubMed ID: 9270901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The selective 5-HT2 receptor antagonist amperozide attenuates 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior.
    Klint T; Dahlgren IL; Larsson K
    Eur J Pharmacol; 1992 Mar; 212(2-3):241-6. PubMed ID: 1601066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin--dopamine interactions in the nigrostriatal system.
    Waldmeier PC; Delini-Stula AA
    Eur J Pharmacol; 1979 May; 55(4):363-73. PubMed ID: 572774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo.
    Nissbrandt H; Waters N; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):12-9. PubMed ID: 1328893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-cholinergic action of exogenous acetylcholinesterase in the rat substantia nigra. II. Long-term interactions with dopamine metabolism.
    Hawkins CA; Greenfield SA
    Behav Brain Res; 1992 Jun; 48(2):159-63. PubMed ID: 1616606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral effects of amylin injected intracerebroventricularly in the rat.
    Clementi G; Valerio C; Emmi I; Prato A; Drago F
    Peptides; 1996; 17(4):589-91. PubMed ID: 8804066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.